We are live on ! Find out more
Northern Trust

Northern Trust Portfolio holdings

AUM $757B
1-Year Est. Return 28.64%
 

Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.

This Fund
S&P 500
This Quarter Est. Return
-12.77%
1 Year Est. Return
+28.64%
3 Year Est. Return
+94.48%
5 Year Est. Return
+125.76%
10 Year Est. Return
+523.41%
AUM
$357B
AUM Growth
-$52.1B
Cap. Flow
+$7.49B
Cap. Flow %
2.1%
Top 10 Hldgs %
15.53%
Holding
4,401
New
95
Increased
1,835
Reduced
2,070
Closed
125

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$994M
2
CI icon
Cigna
CI
+$524M
3
MSFT icon
Microsoft
MSFT
+$395M
4
AMZN icon
Amazon
AMZN
+$281M
5
CVS icon
CVS Health
CVS
+$265M

Sector Composition

Rank Sector Weight
1 Technology 15.98%
2 Financials 14.41%
3 Healthcare 13.78%
4 Consumer Discretionary 9.86%
5 Industrials 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APVO icon
3951
Aptevo Therapeutics
APVO
$5.11M
0
JAKK icon
3952
Jakks Pacific
JAKK
$291M
$87K ﹤0.01%
5,946
-140
-2% -$3.17K
SVBI
3953
DELISTED
Severn Bancorp Inc/MD
SVBI
$87K ﹤0.01%
10,994
AXSM icon
3954
Axsome Therapeutics
AXSM
$11.5B
$86K ﹤0.01%
30,515
SRTS icon
3955
Sensus Healthcare
SRTS
$50.2M
$86K ﹤0.01%
+11,626
New +$73.8K
UONEK icon
3956
Urban One Class D
UONEK
$24.9M
$86K ﹤0.01%
5,337
FTD
3957
DELISTED
FTD Companies, Inc. Common Stock
FTD
$85K ﹤0.01%
57,554
-3,898
-6% -$8.29K
EVOK
3958
DELISTED
Evoke Pharma
EVOK
$84K ﹤0.01%
236
VTVT icon
3959
vTv Therapeutics
VTVT
$137M
$84K ﹤0.01%
794
+7
+0.9% +$648
FOMX
3960
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$84K ﹤0.01%
23,271
-462
-2% -$2.01K
CHRN
3961
ChronoScale Holdings
CHRN
$2.78B
$83K ﹤0.01%
296
-36
-11% -$15.4K
GLMD icon
3962
Galmed Pharmaceuticals
GLMD
$4.95M
$83K ﹤0.01%
68
+10
+17% +$17.5K
INOD icon
3963
Innodata
INOD
$2.05B
$83K ﹤0.01%
55,374
-1,000
-2% -$1.54K
CVEO icon
3964
Civeo
CVEO
$330M
$82K ﹤0.01%
4,787
-161
-3% -$4.75K
OIG
3965
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$82K ﹤0.01%
1,667
RIOT icon
3966
Riot Platforms
RIOT
$7.31B
$81K ﹤0.01%
53,877
-2,800
-5% -$6.22K
INTX
3967
DELISTED
Intersections, Inc.
INTX
$80K ﹤0.01%
21,449
-2,211
-9% -$6.64K
OMEX icon
3968
Odyssey Marine Exploration
OMEX
$50.9M
$79K ﹤0.01%
23,726
+226
+1% +$1.38K
RDVT icon
3969
Red Violet
RDVT
$913M
$79K ﹤0.01%
11,676
ATXI
3970
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$79K ﹤0.01%
+13
New +$62.2K
BCRH
3971
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
$79K ﹤0.01%
14,364
-14
-0.1% -$105
ZVRA icon
3972
Zevra Therapeutics
ZVRA
$673M
$78K ﹤0.01%
2,715
+688
+34% +$27.8K
XENE icon
3973
Xenon Pharmaceuticals
XENE
$6.14B
$77K ﹤0.01%
12,246
+1,948
+19% +$17.3K
IRD
3974
Opus Genetics
IRD
$307M
$77K ﹤0.01%
1,721
ALIM
3975
DELISTED
Alimera Sciences
ALIM
$77K ﹤0.01%
7,154

Similar funds

Northern Trust's Q4 2018 Portfolio in Review

As of Q4 2018, Northern Trust held 4,401 positions worth $357B, down 13% from $409B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 5%. Northern Trust opened 95 new positions and exited 125, leaving the 4,401-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Northern Trust's largest Q4 2018 buy was Linde: 6,288,266 shares worth $981M.
  • Northern Trust added most to Cigna in Q4 2018, an estimated $524M increase.
  • Northern Trust's biggest Q4 2018 reduction was FlexShares iBoxx 3-Year Target Duration TIPS Index Fund, cutting an estimated $224M.
  • Northern Trust fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $918M.
  • Northern Trust's ten largest holdings make up 16% of its $357B portfolio in Q4 2018.
  • Northern Trust opened 95 new positions and closed 125 in Q4 2018.
  • Northern Trust's portfolio value fell 13% quarter-over-quarter to $357B.

Based on Northern Trust's 13F filing for Q4 2018, filed 12 Feb 2019.